Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor
Clinical Pharmacology Advances and Applications（2021）
Key words
drug-drug interactions,D-2/D-3 dopamine receptor antagonist,gastroparesis,pharmacokinetics,QT effects
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined